DMAC — DiaMedica Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for DiaMedica Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	27.5	45.1	33.5	52.9	44.1
Net Total Accounts Receivable
Net Total Receivables	0.34	0.13	0.082	0.369	0.236
Prepaid Expenses
Total Other Current Assets
Total Current Assets	27.9	45.4	33.8	53.7	44.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.174	0.112	0.56	0.485	0.427
Other Long Term Assets
Total Assets	28.1	45.6	34.4	54.2	46.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	2.03	1.52	2.17	2.79	5.39
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.08	1.53	2.57	3.1	5.63
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	26	44	31.8	51.1	40.7
Total Liabilities & Shareholders' Equity	28.1	45.6	34.4	54.2	46.3
Total Common Shares Outstanding